Great Power Competition


Your wireless provider. Where your medications come from. Your favorite news sources. You may not know it, but today’s Great Power Competition touches every aspect of your life. In the U.S.’s ideological, economic, and military struggle with China and Russia, the tools behind our daily routines become high-value targets.

MITRE is helping safeguard these basics and helping the U.S. secure its position as world leader. How? By mining early trend lines across sectors to connect what Americans care about with national security. Our citizen-centric metrics and situational awareness tools pinpoint indicators of imbalance—in economics, healthcare, education, defense, telecommunications, R&D, manufacturing, and other areas.

So, how do GPC threats play out in daily life?

aerial view of a container ship in rough seasThe safety of our food, drug, and medical equipment supply chains, for one. The U.S. has become dependent on imported goods, including drugs and medical devices, largely made in China. The coronavirus pandemic has amplified the dangers of relying so heavily on one source for these necessities.

Dominating fifth generation wireless technology (5G) is another key prize. The country with the biggest 5G stake will expand its influence far and wide—for better or worse. Also in the balance: identity and personal data, election integrity, and intellectual property.

MITRE’s unique vantage point is helping government connect the dots across sectors and take early, effective action—and come out on top in today’s GPC.

Medications required to preserve, protect, and save lives are in critical shortage. Monique Mansoura, MITRE executive director of global health security and biotechnology, is using data analytics to improve biopharma infrastructure and minimize dependency on foreign suppliers.

U.S. Drug Supply Safety

The number of COUNTERFEIT DRUG INVESTIGATIONS opened by the FDA in FY 2010

illustration of a syringe
vials of insulin were stolen in 2009 and only 2% were recovered. The stolen temperature-sensitive product was subject to conditions that affected its potency, yet was sold to pharmacies and dispensed to patients.

THE UNITED STATES IMPORTS the most pharmaceuticals and medicines by weight from China.

ONLY 10% of the pharmaceutical ingredient factories listed in generic drug applications are in the United States. 40% are located in India.

We need to ensure that as we prioritize where we’re going to compete on a world stage, our work provides security to citizens across America. This is key to public security in an economic and personal well-being sense.

Beth Meinert
MITRE Vice President and Director, Center for Government Effectiveness and Modernization

Copyright © 2022 MITRE #21-0823 3-16-2021

MITRE is a registered trademark of The MITRE Corporation. Material on this site may be copied and distributed with permission only.